SARA BROWN: Open Payments
NPI 1861145732 · QUINCY, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$571 in 30 payments from 12 companies in 2025. Trend: 2023 $16 · 2024 $288 · 2025 $571
Food & beverage: $571
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $139 |
| Amgen Inc. | 5 | $86 |
| Exact Sciences Corporation | 3 | $61 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $55 |
| E.R. Squibb & Sons, L.L.C. | 1 | $54 |
| Novartis Pharmaceuticals Corporation | 2 | $36 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| Phathom Pharmaceuticals, Inc. | 2 | $30 |
| Boston Scientific Corporation | 1 | $24 |
| Lilly USA, LLC | 1 | $24 |
Products named: Ozempic, REPATHA, Cologuard Collection Kit, CAPLYTA, Wegovy, SHINGRIX, VOQUEZNA, Rybelsus.
Industry payments across IL — which companies pay providers there.
